Biologics CollPlant Renews Distribution Agreement for Its Soft Tissue Repair Product Vergenix™STR With Arthrex a World Leader in Orthopedics byJosh SandbergMarch 18, 2019
Biologics CollPlant Receives Research and Development Project Approval From the Israel Innovation Authority to Advance its Collagen-based BioInk for 3D Printing of Tissues and Organs byJosh SandbergJune 26, 2018
Biologics CollPlant Expands European Sales Network: The Company Has Signed a Distribution Agreement in Greece and Cyprus for Vergenix®FG byJosh SandbergNovember 28, 2017
Financial Top Stories CollPlant in Advanced Negotiations for US Private Placement of USD 5.0 million; Agreement Includes Plan for NASDAQ Uplisting byJosh SandbergSeptember 6, 2017
Biologics Sports Medicine CollPlant Provides Commercial and Operational Update byJosh SandbergMarch 30, 2017
Financial CollPlant Receives Chief Scientist’s Authorization for a NIS 12 Million Research and Development Projects with Funding of Approximately 50% byJosh SandbergJune 1, 2016
Recon CollPlant Reports Positive Interim Trial Results for Vergenix™STR, Indicated for the Treatment of Tendinopathy byJosh SandbergDecember 9, 2015
